Home LiteratureArticle Details
PMID: 1404592 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein.

Journal of virology ·Vol. 66 ·No. 11 ·1992-11-00 ·Pages 6288-93

Schreck R, Grassmann R, Fleckenstein B, Baeuerle PA

Abstract

Oxygen radical scavengers, such as dithiocarbamates and cysteine derivatives, inhibit activation of the ubiquitous transcription factor nuclear factor kappa B (NF-kappa B) after treatment of cells with tumor necrosis factor, phorbol ester, and interleukin-1. An involvement of oxygen radicals was more directly evident from the induction of NF-kappa B by low concentrations of H2O2 and the demonstration that cells stimulated with various NF-kappa B inducers release H2O2 and superoxide. In this study, we used the antioxidant pyrrolidine dithiocarbamate (PDTC) to investigate whether the activation of NF-kappa B by the viral transactivator Tax from human T-cell leukemia virus type I also depends on the production of reactive oxygen intermediates. The Tax-induced activation of the DNA-binding activity of NF-kappa B in Jurkat T cells was potently suppressed by micromolar concentrations of PDTC. Within the same concentration range, PDTC and two other dithiocarbamates also strongly interfered with transactivation of the long terminal repeat (LTR) of human immunodeficiency virus type 1 by Tax but had no effect on transactivation of the same LTR by Tat. Transactivation of the human T-cell leukemia virus type I LTR by Tax was also barely influenced. Tax seems to activate NF-kappa B by a mechanism shared with all other inducers of NF-kappa B tested so far. It appears that one of the pleiotropic activities of Tax leads to an enhanced production of oxygen radicals that are required for activation of NF-kappa B.

MeSH Terms
Antioxidants/pharmacology Dose-Response Relationship, Drug Free Radicals/metabolism Gene Expression Regulation, Viral Gene Products, tat/pharmacology Gene Products, tax/pharmacology HIV Long Terminal Repeat Human T-lymphotropic virus 1/metabolism Models, Biological NF-kappa B/drug effects Oxygen/metabolism Pyrrolidines/pharmacology T-Lymphocytes/metabolism Thiocarbamates/pharmacology Transcription, Genetic Transcriptional Activation
Chemicals
Antioxidants Free Radicals Gene Products, tat Gene Products, tax NF-kappa B Pyrrolidines Thiocarbamates pyrrolidine dithiocarbamic acid Oxygen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Schreck R
Laboratory for Molecular Biology, Ludwig-Maximilians University Munich, Martinsried, Germany.
Grassmann R
Fleckenstein B
Baeuerle P A
References (52)
52 references, click to expand
  1. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
    J Exp Med. 1992 May 1;175(5):1181-94 PMID: 1314883
  2. trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences.
    Virology. 1991 Jun;182(2):874-8 PMID: 2024503
  3. Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization.
    EMBO J. 1992 Aug;11(8):2991-3001 PMID: 1639069
  4. Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus.
    Virology. 1991 Jul;183(1):381-5 PMID: 1647074
  5. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.
    JAMA. 1991 Mar 27;265(12):1538-44 PMID: 1671884
  6. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.
    EMBO J. 1992 Jan;11(1):205-13 PMID: 1740106
  7. Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I.
    J Virol. 1991 Mar;65(3):1420-6 PMID: 1847461
  8. Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS.
    Ann Clin Lab Sci. 1991 Jan-Feb;21(1):70-81 PMID: 1849385
  9. The biochemistry of AIDS.
    Annu Rev Biochem. 1991;60:577-630 PMID: 1883204
  10. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.
    Science. 1991 Aug 30;253(5023):1026-8 PMID: 1887217
  11. Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives.
    AIDS. 1991 May;5(5):497-503 PMID: 1907460
  12. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
    Genes Dev. 1991 Aug;5(8):1464-76 PMID: 1907941
  13. Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate.
    Biol Chem Hoppe Seyler. 1990 Oct;371(10):1021-5 PMID: 1963784
  14. Suppression of signals required for activation of transcription factor NF-kappa B in cells constitutively expressing the HTLV-I Tax protein.
    New Biol. 1990 Oct;2(10):894-902 PMID: 1964088
  15. Inhibition of HIV progression by dithiocarb. German DTC Study Group.
    Lancet. 1990 Mar 24;335(8691):679-82 PMID: 1969060
  16. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.
    EMBO J. 1989 Dec 20;8(13):4251-8 PMID: 2556267
  17. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha.
    Biochem J. 1989 Oct 15;263(2):539-45 PMID: 2556998
  18. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.
    Virology. 1989 Apr;169(2):479-84 PMID: 2705309
  19. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.
    EMBO J. 1991 Jul;10(7):1817-25 PMID: 2050119
  20. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.
    EMBO J. 1991 Aug;10(8):2247-58 PMID: 2065663
  21. Activation of human immunodeficiency virus type 1 by oxidative stress.
    AIDS Res Hum Retroviruses. 1990 Dec;6(12):1389-97 PMID: 2078416
  22. Induction of nuclear NF-kappa B DNA binding activity after exposure of lymphoid cells to soluble tax1 protein.
    New Biol. 1990 Nov;2(11):1034-43 PMID: 2101630
  23. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1.
    J Virol. 1990 Jun;64(6):2932-40 PMID: 2159554
  24. Immediate-early transcription regulation of human cytomegalovirus.
    Curr Top Microbiol Immunol. 1990;154:3-19 PMID: 2161324
  25. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.
    J Exp Med. 1990 Jul 1;172(1):253-61 PMID: 2193097
  26. Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: all contain a leucine zipper structure and basic amino acid domain.
    EMBO J. 1990 Aug;9(8):2537-42 PMID: 2196176
  27. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.
    Cell. 1990 Aug 24;62(4):757-67 PMID: 2201451
  28. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Cell. 1990 Nov 16;63(4):803-14 PMID: 2225078
  29. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):9943-7 PMID: 2263644
  30. Tax1 induction of the HTLV-I 21 bp enhancer requires cooperation between two cellular DNA-binding proteins.
    EMBO J. 1990 Mar;9(3):957-64 PMID: 2311587
  31. Hepatitis B virus X gene can transactivate heterologous viral sequences.
    Proc Natl Acad Sci U S A. 1989 Mar;86(6):2046-50 PMID: 2538828
  32. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Proc Natl Acad Sci U S A. 1989 Jul;86(13):5168-72 PMID: 2740349
  33. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins.
    J Virol. 1989 Apr;63(4):1578-86 PMID: 2784507
  34. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
    EMBO J. 1989 Mar;8(3):757-64 PMID: 2785919
  35. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
    Science. 1987 Dec 11;238(4833):1575-8 PMID: 2825351
  36. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.
    Nature. 1988 Jun 23;333(6175):776-8 PMID: 2838755
  37. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product.
    Science. 1988 Jul 1;241(4861):89-92 PMID: 2838905
  38. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.
    Science. 1988 Sep 23;241(4873):1652-5 PMID: 2843985
  39. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Jul 5;229(4708):69-73 PMID: 2990040
  40. Autoregulation of the human cytomegalovirus major immediate-early gene.
    J Virol. 1985 Dec;56(3):676-82 PMID: 2999424
  41. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
    Nature. 1987 Apr 16-22;326(6114):711-3 PMID: 3031512
  42. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.
    Cell. 1988 Apr 22;53(2):211-7 PMID: 3129195
  43. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  44. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
    Proc Natl Acad Sci U S A. 1982 Nov;79(22):6777-81 PMID: 6294651
  45. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.
    Science. 1984 Jul 27;225(4660):381-5 PMID: 6330891
  46. The actions of metabolic fate of disulfiram.
    Annu Rev Pharmacol Toxicol. 1981;21:575-96 PMID: 7016017
  47. A role for oxygen radicals as second messengers.
    Trends Cell Biol. 1991 Aug;1(2-3):39-42 PMID: 14731549
  48. DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition.
    J Biol Chem. 1991 Jan 5;266(1):252-60 PMID: 1985897
  49. A novel HIV-1 isolate containing alterations affecting the NF-kappa B element.
    Virology. 1991 Mar;181(1):150-7 PMID: 1994572
  50. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.
    Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80 PMID: 2018779
  51. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
    Nature. 1991 Apr 25;350(6320):709-12 PMID: 2023633
  52. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.
    J Virol. 1992 Jul;66(7):4570-5 PMID: 1351105
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-11-00
Pages
6288-93
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC240120
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]